WASHINGTON (AP) — President Donald Trump held talks with Turkish President Recep Tayyip Erdogan at the White House on Thursday and signaled that the United States might soon lift its hold on sales of ...

India’s defence spending must rise to 2.5–3 percent of GDP from the current 2 percent level, Defence Secretary Rajesh Kumar Singh said at Network18’s Reforms Reloaded summit on September 22. “We can ...

Pfizer PFE-3.43%decrease; red down pointing triangle has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera MTSR 1.16%increase; green up pointing triangle in a deal that gets the ...

New research has revealed that a single session of weight training can help fight breast cancer. Researchers at Edith Cowan University in Australia investigated how resistance training and ...

Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...

Pfizer said today it would acquire weight-loss drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, to secure its position in the lucrative obesity treatment ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

By Mariam Sunny and Michael Erman (Reuters) - Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a ...

Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker back into the burgeoning market for obesity drugs. Pfizer on Monday said ...

Investing.com-- Pfizer Inc (NYSE: PFE) is close to launching a $7.3 billion takeover offer for anti-obesity drug maker Metsera Inc (NASDAQ: MTSR), which could be the former’s biggest deal in two years ...